|
HY-117727A-5mg
|
MedChemexpress LLC
|
Leriglitazone (hydrochloride) [CAS 146062-46-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-125286-1mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-10mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-100mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-25mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-5mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-50mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-14442-5mg
|
MedChemexpress LLC
|
ML 10302 (hydrochloride) [CAS 186826-17-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-16677A-10mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-100mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-5mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-50mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0290-100mg
|
MedChemexpress LLC
|
Pranlukast [CAS 103177-37-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290-500mg
|
MedChemexpress LLC
|
Pranlukast [CAS 103177-37-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290A-100mg
|
MedChemexpress LLC
|
Pranlukast (hemihydrate) [CAS 150821-03-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290A-50mg
|
MedChemexpress LLC
|
Pranlukast (hemihydrate) [CAS 150821-03-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0233-1mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-10mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-25mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-5mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-1mL
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16677A-1mL
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0290-1mL
|
MedChemexpress LLC
|
Pranlukast [CAS 103177-37-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290A-1mL
|
MedChemexpress LLC
|
Pranlukast (hemihydrate) [CAS 150821-03-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N0233-1mL
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
